Search results
Showing 616 to 630 of 1284 results for social care
Evidence-based recommendations on pegunigalsidase alfa (Elfabrio) for Fabry disease (also known as alpha-galactosidase deficiency) in adults.
assessment framework Supporting the health and care system to implement virtual wards Social care General practice - keep...
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.
Agenda and papers of the NICE public board meeting on 25 September 2024
Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.
Onasemnogene abeparvovec for treating spinal muscular atrophy (HST15)
Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies.
International collaboration with NICE
This guideline covers needle and syringe programmes for people (including those under 16) who inject drugs. The main aim is to reduce the transmission of viruses and other infections caused by sharing injecting equipment, such as HIV, hepatitis B and C. In turn, this will reduce the prevalence of blood-borne viruses and bacterial infections, so benefiting wider society.
This guideline covers interventions to prevent sexually transmitted infections (STIs) in people aged 16 and over. It aims to reduce the transmission of all STIs, including HIV, and includes ways to help increase the uptake of STI testing and vaccines for human papillomavirus (HPV) and hepatitis A and B.
Learn more about what NICE content is available for reuse by checking our information asset register.
Find out how and where you can reuse NICE's content. Includes use of our content in the UK, use of our content internationally, use of our content for AI purposes, our content assurance process, and our information asset register.
Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTG676)
Early value assessment (EVA) guidance on digitally enabled therapies for adults with anxiety disorders.
guidance"}}]} NICE guidance implementation toolkits To support health and care organisations in putting evidence-based recommendations...
Membership details, terms of reference and future meeting dates for our quality standards advisory committee.